title: Overexpression of beta3/gamma2 chains of laminin-5 and MMP7 in biliary cancer.
abstract: OBJECTIVE
  To clarify the clinicopathological significance of laminin-5 gamma2 (LNgamma2) and beta3 (LNbeta3) chains and MMP7 expression in biliary tract cancer.
  
  
  METHODS
  We analyzed the association between immunohistochemically detected LNgamma2, LNbeta3, and MMP7 expression in biliary tract cancer and clinicopathological characteristics. Activity of MMP7 was analyzed by casein zymography. An in vitro invasion assay after treatment with MMP7-specific siRNA was performed.
  
  
  RESULTS
  LNgamma2 expression was predominantly observed in carcinoma cells at the invasive front. LNgamma2 expression was seen in 57% of patients with biliary tract cancer, and was associated with depth of invasion, histologic type, and advanced stage. The expression pattern of LNbeta3 was classified into two types: invasive front dominant type (38%) and diffuse type (28%). The invasive front dominant type was associated with histologic type and advanced stage. MMP7 positivity was correlated with LNgamma2 or LNbeta3 expression but not with clinicopathological characteristics. Active MMP7 detected by casein zymography was correlated with depth of invasion and advanced stage. Downregulation of MMP7 expression by siRNA resulted in a significant decrease in biliary tract cancer cell invasion in vitro.
  
  
  CONCLUSIONS
  Our results suggest that LNgamma2 and LNbeta3, in conjunction with MMP7, play a key role in the progression of biliary tract cancer.
authors.affiliation: First Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
authors.forename: Toshikuni
authors.initials: T
authors.lastname: Oka
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Yamamoto
authors.forename: Shigeru
authors.initials: S
authors.lastname: Sasaki
authors.forename: Masanori
authors.initials: M
authors.lastname: Ii
authors.forename: Keiichi
authors.initials: K
authors.lastname: Hizaki
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Taniguchi
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Adachi
authors.forename: Kohzoh
authors.initials: K
authors.lastname: Imai
authors.forename: Yasuhisa
authors.initials: Y
authors.lastname: Shinomura
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D000368:Aged; D000818:Animals; D001661:Biliary Tract Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D015815:Cell Adhesion Molecules / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D005260:Female; D006801:Humans; D007797:Laminin / Q000235:genetics / Q000378:metabolism*; D008297:Male; D020783:Matrix Metalloproteinase 7 / Q000235:genetics / Q000378:metabolism*; D008875:Middle Aged; D034741:RNA, Small Interfering / Q000235:genetics / Q000378:metabolism; D000097794:Kalinin
chemical_list: D015815:Cell Adhesion Molecules; D007797:Laminin; D020783:Matrix Metalloproteinase 7; D034741:RNA, Small Interfering; D000097794:Kalinin; C400567:LAMC2 protein, human; C095567:laminin alpha 3; C060932:MMP7 protein, human
references.citation: Cell. 1991 May 17;65(4):599-610
references.pmid: 2032285
references.citation: Gastroenterology. 2005 Nov;129(5):1375-83
references.pmid: 16285938
references.citation: Semin Cancer Biol. 2002 Jun;12(3):197-207
references.pmid: 12083850
references.citation: Dis Colon Rectum. 1993 Jul;36(7):627-35
references.pmid: 8348847
references.citation: Int J Cancer. 2001 Sep 20;95(5):290-4
references.pmid: 11494227
references.citation: Cancer Lett. 2007 Aug 28;254(1):42-53
references.pmid: 17374440
references.citation: Oncogene. 2005 Nov 24;24(53):7946-52
references.pmid: 16007117
references.citation: Exp Biol Med (Maywood). 2006 Jan;231(1):20-7
references.pmid: 16380641
references.citation: J Cell Biol. 2000 Feb 7;148(3):615-24
references.pmid: 10662785
references.citation: Clin Cancer Res. 2001 Apr;7(4):896-900
references.pmid: 11309339
references.citation: Am J Pathol. 2001 Mar;158(3):1129-35
references.pmid: 11238061
references.citation: J Pathol. 1998 May;185(1):44-52
references.pmid: 9713359
references.citation: Cancer Res. 1999 Jul 15;59(14):3313-6
references.pmid: 10416584
references.citation: Am J Pathol. 1994 Oct;145(4):782-91
references.pmid: 7943170
references.citation: Cancer Res. 1995 Sep 15;55(18):4132-9
references.pmid: 7664291
references.citation: Science. 1997 Jul 11;277(5323):225-8
references.pmid: 9211848
references.citation: Clin Chem. 2004 Mar;50(3):490-9
references.pmid: 14726470
references.citation: Cancer Res. 2001 Nov 15;61(22):8089-93
references.pmid: 11719433
references.citation: J Pathol. 2007 May;212(1):102-11
references.pmid: 17370299
references.citation: J Pathol. 2007 Oct;213(2):131-9
references.pmid: 17724792
references.citation: Pathol Int. 2004 Sep;54(9):688-92
references.pmid: 15363037
references.citation: Curr Probl Surg. 2007 Jul;44(7):396-482
references.pmid: 17693325
references.citation: Cancer Res. 1999 Nov 1;59(21):5596-601
references.pmid: 10554040
references.citation: Gastroenterology. 1997 Apr;112(4):1290-6
references.pmid: 9098015
references.citation: Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3684-91
references.pmid: 14506159
references.citation: Carcinogenesis. 2004 Dec;25(12):2353-60
references.pmid: 15333466
references.citation: FEBS Lett. 1995 Jul 24;368(3):556-8
references.pmid: 7635220
references.citation: Mol Carcinog. 2001 Feb;30(2):119-29
references.pmid: 11241759
references.citation: Cancer Res. 2006 Dec 1;66(23):11228-37
references.pmid: 17145868
references.citation: Am J Pathol. 1995 Oct;147(4):1123-32
references.pmid: 7573357
references.citation: J Biochem. 1996 Dec;120(6):1196-202
references.pmid: 9010770
references.citation: J Pathol. 2007 Apr;211(5):516-523
references.pmid: 17318812
references.citation: Am J Pathol. 1999 Oct;155(4):1033-8
references.pmid: 10514384
references.citation: Crit Rev Oncol Hematol. 2007 Jan;61(1):44-51
references.pmid: 17164111